| Financial Year |
March 31 2023 |
| Monetary Funds |
334,771,557.18 |
| Held-for-trading Financial Assets |
659,432,061.56 |
| Notes Receivable |
754,670.50 |
| Accounts Receivable |
118,383,530.59 |
| Advances to Suppliers |
12,500,932.05 |
| Other Receivables |
5,012,133.25 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
421,094,228.04 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,055,912.52 |
| Total Current Assets |
1,717,642,021.05 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
164,382,521.15 |
| Under-construction Projects |
94,776,524.74 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
20,365,798.51 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
482,074.76 |
| Deferred Income Tax Assets |
30,029,685.23 |
| Other Non-Current Assets |
20,756,223.42 |
| Sub-Total of Non-Current Assets |
373,538,523.41 |
| Total Assets |
2,091,180,544.46 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
111,234,524.02 |
| Accounts Payable |
76,292,636.03 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,913,514.81 |
| Taxes Payable |
5,564,986.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
660,627.11 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,284,396.36 |
| Other Current Liabilities |
18,512,528.49 |
| Sub-Total of Current Liabilities |
518,752,627.69 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,166,339.36 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
74,852,100.68 |
| Total Liabilities |
593,604,728.37 |
| Paid-In Capital(Or Share Stock) |
252,176,000.00 |
| Capital Surplus |
828,824,234.32 |
| Surplus Reserve |
62,821,144.51 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
339,495,735.91 |
| Minority Stockholder's Interest |
14,130,859.16 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,483,444,956.93 |
| Owner's Equity（Stockholder's Equity） |
1,497,575,816.09 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,091,180,544.46 |
